These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 35525959)

  • 1. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.
    Zhang LX; Gao J; Long X; Zhang PF; Yang X; Zhu SQ; Pei X; Qiu BQ; Chen SW; Lu F; Lin K; Xu JJ; Wu YB
    Mol Cancer; 2022 May; 21(1):110. PubMed ID: 35525959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
    Chen Y; Wu Y
    Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.
    Ying X; Zhu J; Zhang Y
    Mol Genet Genomic Med; 2019 Dec; 7(12):e991. PubMed ID: 31573758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578.
    Wang M; Ma M; Yang Y; Li C; Wang Y; Sun X; Wang M; Sun Y; Jiao W
    Thorac Cancer; 2021 Aug; 12(16):2258-2264. PubMed ID: 34236145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
    Liu S; Jiang Z; Xiao P; Li X; Chen Y; Tang H; Chai Y; Liu Y; Zhu Z; Xie Q; He W; Ma Y; Jin L; Feng W
    Cancer Sci; 2022 Jan; 113(1):79-90. PubMed ID: 34706132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.
    Fan J; Xia X; Fan Z
    J Clin Lab Anal; 2022 Sep; 36(9):e24591. PubMed ID: 35908770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1.
    Gao J; Ao YQ; Zhang LX; Deng J; Wang S; Wang HK; Jiang JH; Ding JY
    J Exp Clin Cancer Res; 2022 Oct; 41(1):295. PubMed ID: 36209117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.
    Zhao X; Wang J; Zhu R; Zhang J; Zhang Y
    Sci Rep; 2021 Oct; 11(1):21014. PubMed ID: 34697393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircTIMELESS regulates the proliferation and invasion of lung squamous cell carcinoma cells via the miR-136-5p/ROCK1 axis.
    Zhang W; Shi J; Cheng C; Wang H
    J Cell Physiol; 2020 Sep; 235(9):5962-5971. PubMed ID: 31960961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Koh YW; Han JH; Haam S; Lee HW
    Anticancer Res; 2024 May; 44(5):2081-2089. PubMed ID: 38677736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma.
    Wang C; Tan S; Liu WR; Lei Q; Qiao W; Wu Y; Liu X; Cheng W; Wei YQ; Peng Y; Li W
    Mol Cancer; 2019 Sep; 18(1):134. PubMed ID: 31484581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01232 promotes lung squamous cell carcinoma progression through modulating miR-181a-5p/SMAD2 axis.
    Zhang D; Hua M; Zhang N
    Am J Med Sci; 2023 Apr; 365(4):386-395. PubMed ID: 36543302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_BBS9 as an early diagnostic biomarker for lung adenocarcinoma: direct interaction with IFIT3 in the modulation of tumor immune microenvironment.
    Peng D; Liang M; Li L; Yang H; Fang D; Chen L; Guan B
    Front Immunol; 2024; 15():1344954. PubMed ID: 39139574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.
    Zhou J; Li P; Zhao X; Zhao Y; Luo J; Deng Y; Jiang N; Xiao Z; Zhang W; Zhou Y; Zhao J; Li P; Li Y; Tian Z
    Respir Res; 2023 Nov; 24(1):276. PubMed ID: 37953225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
    Wang W; Li L; Zhao L
    J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
    Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
    J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.